Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
PBH 
Prestige Brand Holdings Inc (PBH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: PBH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $82.8
1 Year Target Price $82.8
| 3 | Strong Buy |
| 0 | Buy |
| 3 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -11.39% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.35B USD | Price to earnings Ratio 15.97 | 1Y Target Price 82.8 |
Price to earnings Ratio 15.97 | 1Y Target Price 82.8 | ||
Volume (30-day avg) 7 | Beta 0.44 | 52 Weeks Range 62.95 - 90.04 | Updated Date 08/29/2025 |
52 Weeks Range 62.95 - 90.04 | Updated Date 08/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.26 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-06 | When Before Market | Estimate 1.05 | Actual 0.95 |
Profitability
Profit Margin 19.02% | Operating Margin (TTM) 28.76% |
Management Effectiveness
Return on Assets (TTM) 6.47% | Return on Equity (TTM) 12.05% |
Valuation
Trailing PE 15.97 | Forward PE 14.81 | Enterprise Value 4213367141 | Price to Sales(TTM) 2.99 |
Enterprise Value 4213367141 | Price to Sales(TTM) 2.99 | ||
Enterprise Value to Revenue 3.76 | Enterprise Value to EBITDA 11.64 | Shares Outstanding 49214200 | Shares Floating 48647224 |
Shares Outstanding 49214200 | Shares Floating 48647224 | ||
Percent Insiders 1.26 | Percent Institutions 107.87 |
Upturn AI SWOT
Prestige Brand Holdings Inc
Company Overview
History and Background
Prestige Consumer Healthcare Inc. was founded in 1996. It has grown through acquisitions of various over-the-counter (OTC) healthcare and household cleaning brands. The company focuses on acquiring and revitalizing established brands.
Core Business Areas
- North American Over-the-Counter Healthcare: Focuses on the sale of OTC healthcare products in North America, including cough & cold, pain relief, oral care, and feminine hygiene products.
- International Over-the-Counter Healthcare: Focuses on the sale of OTC healthcare products in international markets.
Leadership and Structure
Ron Lombardi is the Chairman, President, and CEO. The organizational structure consists of various departments overseeing brand management, sales, marketing, finance, and operations. It operates with a decentralized structure, emphasizing brand-level autonomy.
Top Products and Market Share
Key Offerings
- Clear Eyes: Eye drops for redness relief. Competitors include Visine (JNJ) and Rohto (Rohto Pharmaceutical Co., Ltd.). Market share around 10-15% in the US. Generated approx. 6-8% of total revenue.
- BC Powder: Pain relief powder for headaches and body aches. Competitors include Goody's Powder (Allegiant Healthcare), Excedrin (GSK). Market share around 5-7% in the US. Generated approx. 4-6% of total revenue.
- Summer's Eve: Feminine hygiene products. Competitors include Massengill (GSK) and other private label brands. Market share approximately 20-25% in the US. Generated approx. 15-18% of total revenue.
- Compeed: Blister treatment bandages. Competitors include Band-Aid (JNJ) and Dr. Scholl's (Bayer). Internationally more significant than domestically. Generated approx. 8-10% of total revenue.
Market Dynamics
Industry Overview
The OTC healthcare industry is characterized by stable growth, driven by an aging population, increasing consumer awareness of self-care, and a shift towards preventative healthcare. Highly regulated with intense competition.
Positioning
Prestige Consumer Healthcare Inc. positions itself as a brand consolidator within the OTC healthcare market. Its competitive advantage lies in acquiring and rejuvenating under-managed brands with strong equity.
Total Addressable Market (TAM)
The global OTC market is estimated to be worth over $200 billion. Prestige is positioned to grow within this market, capturing a small but meaningful percentage.
Upturn SWOT Analysis
Strengths
- Strong brand portfolio
- Established distribution network
- Proven acquisition strategy
- Solid cash flow generation
Weaknesses
- High debt levels
- Dependence on acquisitions for growth
- Limited organic growth
- Brand concentration risk
Opportunities
- Further acquisitions of complementary brands
- Expansion into new geographic markets
- Innovation in existing product lines
- Growing demand for self-care products
Threats
- Increased competition from larger players
- Regulatory changes
- Economic downturns
- Changing consumer preferences
Competitors and Market Share
Key Competitors
- JNJ
- GSK
- BAYRY
Competitive Landscape
Prestige Consumer Healthcare Inc. competes with larger, more diversified companies. Its advantage lies in its focused brand portfolio and acquisition strategy. However, it is more vulnerable to changes in consumer preferences and regulatory pressures than the larger companies.
Major Acquisitions
HydraSense and Colic-Ease
- Year: 2023
- Acquisition Price (USD millions): 230
- Strategic Rationale: Expansion of over-the-counter products.
Growth Trajectory and Initiatives
Historical Growth: Historically, Prestige Consumer Healthcare Inc.'s growth has been driven by acquisitions. Organic growth has been limited.
Future Projections: Analysts project continued growth through further acquisitions and modest organic growth initiatives.
Recent Initiatives: Recent strategic initiatives include focusing on core brands, streamlining operations, and reducing debt.
Summary
Prestige Consumer Healthcare Inc. is a brand consolidator in the OTC healthcare market with a solid portfolio of established brands. Its acquisition-driven strategy and strong cash flow are working well, but its high debt levels and dependence on acquisitions pose potential risks. The company needs to focus on organic growth and deleveraging to improve its long-term sustainability and it must be careful of larger company's ability to quickly respond to a changing competitive landscape.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Analyst Reports
- Industry Research Reports
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Market share estimates are based on available data and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Prestige Brand Holdings Inc
Exchange NYSE | Headquaters Tarrytown, NY, United States | ||
IPO Launch date 2005-02-10 | Chairman, President & CEO Mr. Ronald M. Lombardi CPA | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 600 | Website https://www.prestigebrands.com |
Full time employees 600 | Website https://www.prestigebrands.com | ||
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.